The study points toward the possibility that IFN production, as a part of innate response to viral infection, may play a role in inducing renal disease in patients with high-risk APOL1 alleles and that treatment with exogenous IFN may exacerbate the disease by acting as a second hit. The gene discussed is IFNA1; the disease is kidney disorder.